[HTML][HTML] 达比加群在老年非瓣膜性房颤合并心衰患者中的临床疗效和安全性研究
张金鑫， 戴红艳， 樊纯祯， 荣媛媛， 管军 - Advances in Clinical …, 2023 - hanspub.org
… effect and safety of dabigatran in elderly patients with non valvular atrial fibrillation and …
Methods: 207 elderly NVAF patients with heart failure who received long-term anticoagulation …
Methods: 207 elderly NVAF patients with heart failure who received long-term anticoagulation …
Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long‐term results: 合并心房颤动的糖尿病患者通过左心耳封堵术 …
R Litwinowicz, M Bartus, P Ceranowicz… - Journal of …, 2019 - Wiley Online Library
… evaluate the long-term efficacy of LAAO in DM patients with AF. … patients with non-valvular
AF who underwent LAAO with the Lariat device (SentreHEART, Redwood, CA, USA) between …
AF who underwent LAAO with the Lariat device (SentreHEART, Redwood, CA, USA) between …
[PDF][PDF] 利伐沙班与达比加群治疗老年非瓣膜性房颤有效性和安全性的Meta 分析
周强， 吴燕子， 陶瑛瑛， 黄晓晖， 周国华， 魏萌 - 临床药物治疗杂志, 2021 - lcywzlzz.com
… Con⁃ clusion Rivaroxaban and Dabigatran are similar in efficacy in elderly patients with
non-valvular atrial fibrillation,but the safety of Rivaroxaban are higher than those of Dabigatran. …
non-valvular atrial fibrillation,but the safety of Rivaroxaban are higher than those of Dabigatran. …
心房颤动合并慢性肾脏疾病患者口服抗凝的治疗策略
张卫芳， 熊爱珍， 程晓曙 - 临床心血管病杂志, 2019 - lcxxg.whuhzzs.com
… , efficacy, and safety require special consideration in patients … changes and safety and efficacy
of approved OACs in patients with … dabigatran etexilate in patients with non-valvular atrial …
of approved OACs in patients with … dabigatran etexilate in patients with non-valvular atrial …
[PDF][PDF] 达比加群酯用于预防心房颤动患者脑卒中时致消化道出血的危险因素与预防措施
曾莉莉， 张云琛， 陈惠弟， 赵佳丽 - 中国新药与临床杂志(Chin J New …, 2016 - core.ac.uk
… 研究显示, 非瓣膜性心房颤动(non- valvular atrial fibrillation, … with dabigatran etexilate for
stroke in atrial fibrillation patients … randomized evaluation of long - term anticoagulant therapy (…
stroke in atrial fibrillation patients … randomized evaluation of long - term anticoagulant therapy (…
达比加群酯与利伐沙班在非瓣膜性AF 患者抗凝治疗中的临床效果比较
赵桂梅， 李丽华， 丁以绚 - 心脏杂志, 2022 - heartj.cn
… and safety of different anticoagulant drugs in the clinical treatment of non-valvular atrial …
and dabigatran etexilate achieve ideal clinical efficacy in patients with NVAF, but the lsafety …
and dabigatran etexilate achieve ideal clinical efficacy in patients with NVAF, but the lsafety …
非瓣膜性房颤防治综合策略中左心耳封堵术的助攻
兰贝蒂， 王瑞涛， 谢学刚， 张玉顺 - 心脏杂志, 2021 - heartj.cn
… prevent stroke in patients with non-valvular atrial fibrillation. With … Long-term persistence of
newly initiated warfarin therapy in … Efficacy and safety of left atrial appendage closure versus …
newly initiated warfarin therapy in … Efficacy and safety of left atrial appendage closure versus …
新型口服抗凝血剂在心房颤动患者中胃肠道出血和颅内出血的风险分析: 系统回顾和网络meta 分析
W Xu, S Hu, T Wu, AW Xu, AS Hu… - Journal of Zhejiang …, 2017 - jzus.zju.edu.cn
… (apixaban 5 mg, dabigatran 110 mg, and edoxaban 30 mg). Conclusions: Bayesian network
meta-analysis of treatment of non-valvular AF patients with anticoagulants suggested that …
meta-analysis of treatment of non-valvular AF patients with anticoagulants suggested that …
左心耳封堵术与口服抗凝药物应用于心房颤动患者有效性及安全性的meta 分析
任艳霞， 安智晶， 张得梅， 郭雪娅 - 上海交通大学学报(医学版), 2021 - xuebao.shsmu.edu.cn
… ·To evaluate the efficacy and safety of left atrial appendage … oral anticoagulants(NOAC)] in
non-valvular atrial fibrillation (AF). … The effect of dabigatran plasma concentrations and patient …
non-valvular atrial fibrillation (AF). … The effect of dabigatran plasma concentrations and patient …
合并慢性肾脏疾病的心房颤动患者的治疗
张涛， 杨艳敏 - 中华心脏与心律电子杂志, 2022 - zhxzyxldzzz.cma-cmc.com.cn
… scores at predicting thromboembolic event in non-anticoagulated and anticoagulated
patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2015, 15:156. …
patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2015, 15:156. …